跳到正文
原文
Endpoints News 生物医药· Alex Hoffman·· 2026-10-02AI 评分21

Moderna 与 Neurocrine 迎回老将,Pharming CEO 因与董事会分歧离任

Moderna, Neurocrine bring back familiar faces; Pharming CEO exits after clashing with board

AI 导读

Juan Andres 将于 10 月 5 日结束退休,重新出任 Moderna 首席运营官(COO)。Pharming 首席执行官因与董事会产生分歧而退出。这两家公司的人事变动涉及高管回归及 CEO 离任。

正文

→ Juan An­dres will come out of re­tire­ment to re­join Mod­er­na as COO on Oct. 5, bring­ing his in­ti­mate knowl­edge of the com­pa­ny as its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news